![Michael W. Hofmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael W. Hofmann
Keine laufenden Positionen mehr
Profil
Michael W.
Hofmann worked as the Chief Executive Officer at X2-Pharma GmbH and as the Director of Biological Research at Alantos Pharmaceuticals Holding, Inc. Prior to that, he held Principal positions at Ruprecht-Karls-Universität Heidelberg, the University of Mannheim, and BioReliance Manufacturing GmbH.
Hofmann earned a doctorate degree from Ruprecht-Karls-Universität Heidelberg.
Ehemalige bekannte Positionen von Michael W. Hofmann
Unternehmen | Position | Ende |
---|---|---|
BioReliance Manufacturing GmbH | Corporate Officer/Principal | - |
University of Mannheim | Corporate Officer/Principal | - |
X2-Pharma GmbH
![]() X2-Pharma GmbH Pharmaceuticals: MajorHealth Technology X2-Pharma GmbH develops pharmaceutical products for the treatment of inflammatory diseases. It is a biopharmaceutical company that offers small molecule pharmaceuticals for the treatment of inflammatory diseases. The company is headquartered in Heidelberg, Germany. | Corporate Officer/Principal | - |
Ruprecht-Karls-Universität Heidelberg | Corporate Officer/Principal | - |
Alantos Pharmaceuticals Holding, Inc.
![]() Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
Ausbildung von Michael W. Hofmann
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Alantos Pharmaceuticals Holding, Inc.
![]() Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Health Technology |
BioReliance Manufacturing GmbH | Health Technology |
X2-Pharma GmbH
![]() X2-Pharma GmbH Pharmaceuticals: MajorHealth Technology X2-Pharma GmbH develops pharmaceutical products for the treatment of inflammatory diseases. It is a biopharmaceutical company that offers small molecule pharmaceuticals for the treatment of inflammatory diseases. The company is headquartered in Heidelberg, Germany. | Health Technology |